Bifidobacterium animalis subsp. lactis as adjunct to non-surgical periodontal treatment in periodontitis: a randomized controlled clinical trial
Clinical Oral Investigations · 2023
DOI: 10.1007/s00784-023-04870-1 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Investigations, 2023. Verfasst von Hafize Öztürk Özener und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Faculty of Dentistry, Marmara University, Basıbuyuk, Maltepe, Istanbul, Turkey. hafize.ozturk@marmara.edu.tr. Hauptthemen laut MEDLINE: Bifidobacterium animalis, Chronic Periodontitis, Dental Plaque, Probiotics. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: The purpose of this study is to investigate the clinical and microbiological effects of Bifidobacterium animalis subsp. lactis DN-173010 containing yogurt as an adjunct to non-surgical periodontal treatment in periodontitis patients. MATERIALS AND METHODS: This is a prospective randomized controlled clinical study registered with NCT05408364 under clinical trial registration. Thirty periodontitis patients were divided into 2 groups at random. As adjunctive to supra and subgingival instrumentation, the test group consumed Bifidobacterium animalis subsp. lactis DN-173010 containing yogurt while the control group consumed natural yogurt, once daily for 28 days. The plaque index (PI), gingival index (GI), bleeding on probing (BOP), probing depth (PD), and clinical attachment level (CAL) were recorded at baseline, 28th day, and 3rd month. Microbiological analysis was performed using culture method by obtaining subgingival plaque samples from 2 periodontal sites with 4≤PD≤6 mm at the same time points. RESULTS: The inter-group comparisons of PI, GI, and BOP as well as the changes between the measurement time points were statistically significant in favor of the test group. There were no significant differences in terms of PD and CAL changes between the study groups at all times (∆baseline-28 days, ∆baseline-3 months) (p>0.05). The number of patients presenting subgingival Bifidobacterium species was significantly greater in the test group than the control group at the 28th day (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Periodontology, Faculty of Dentistry, Marmara University, Basıbuyuk, Maltepe, Istanbul, Turkey. hafize.ozturk@marmara.edu.tr.
- Department of Periodontology, Faculty of Dentistry, Marmara University, Basıbuyuk, Maltepe, Istanbul, Turkey.
- Department of Basic Health Sciences, Faculty of Dentistry, Marmara University, Istanbul, Turkey.
- Department of Periodontology, Faculty of Dentistry, Yeditepe University, Istanbul, Turkey.
ORCID-Profile: Hafize Öztürk Özener, Leyla Kuru, Tanju Kadir, Bahar Kuru
Zitieren
APA
Özener, H. Ö., Kuru, L., Kadir, T., & Kuru, B. (2023). Bifidobacterium animalis subsp. lactis as adjunct to non-surgical periodontal treatment in periodontitis: a randomized controlled clinical trial. Clinical Oral Investigations. https://doi.org/10.1007/s00784-023-04870-1
Vancouver
Özener HÖ, Kuru L, Kadir T, Kuru B. Bifidobacterium animalis subsp. lactis as adjunct to non-surgical periodontal treatment in periodontitis: a randomized controlled clinical trial. Clinical Oral Investigations. 2023. doi:10.1007/s00784-023-04870-1
BibTeX
@article{zener2023,
author = {Özener, Hafize Öztürk and Kuru, Leyla and Kadir, Tanju and Kuru, Bahar},
title = {Bifidobacterium animalis subsp. lactis as adjunct to non-surgical periodontal treatment in periodontitis: a randomized controlled clinical trial},
journal = {Clinical Oral Investigations},
year = {2023},
doi = {10.1007/s00784-023-04870-1}
}
EUVIMED